Although studies of METTL1 have been limited, overexpression of METTL1 could drive tumor progression which was reported in hepatocellular carcinoma, colon cancer, intrahepatic cholangiocarcinoma, and lung cancer (9–13). Here, METTL1 is linked to malignant colon neoplasm.